Molecular Cancer Therapeutics CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Minguez, J. M.
Right arrow Articles by Day, B. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Minguez, J. M.
Right arrow Articles by Day, B. W.
Vol. 1, 1305-1313, December 2002     Molecular Cancer Therapeutics
© 2002 American Association for Cancer Research

Synthesis and High Content Cell-based Profiling of Simplified Analogues of the Microtubule Stabilizer (+)-Discodermolide 1

Jose M. Minguez, Kenneth A. Giuliano, Raghavan Balachandran, Charitha Madiraju, Dennis P. Curran and Billy W. Day2

Department of Chemistry, University of Pittsburgh, Pittsburgh, Pennsylvania 15260 [J. M. M., D. P. C., B. W. D.] Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania 15261 [R. B., C. M., B. W. D.] and Cellomics, Inc., Pittsburgh, Pennsylvania 15219 [K. A. G.]

(+)-Discodermolide, a C24:4, trihydroxylated, octamethyl, carbamate-bearing fatty acid lactone originally isolated from a Caribbean sponge, has proven to be the most potent of the microtubule-stabilizing agents. Recent studies suggest that it or its analogues may have advantages over other classes of microtubule-stabilizing agents. (+)-Discodermolide’s complex molecular architecture has made structure-activity relationship analysis in this class of compounds a formidable task. The goal of this study was to prepare simplified analogues of (+)-discodermolide and to analyze their biological activities to expand structure-activity relationships. A small library of analogues was prepared wherein the (+)-discodermolide methyl groups at C-14 and C-16 and the C-7 hydroxyl were removed, and the lactone was replaced by simple esters. The library components were analyzed for microtubule-stabilizing actions in vitro, antiproliferative activity against a small panel of human carcinoma cells, and cell signaling, microtubule architecture and mitotic spindle alterations by a multiparameter fluorescence cell-based screening technique. The results show that even drastic structural simplification can lead to analogues with actions related to microtubule targeting and signal transduction, but that these subtle effects were illuminated only through the high information content cell-based screen.




This article has been cited by other articles:


Home page
J Biomol ScreenHome page
F. Gasparri, P. Cappella, and A. Galvani
Multiparametric Cell Cycle Analysis by Automated Microscopy
J Biomol Screen, September 1, 2006; 11(6): 586 - 598.
[Abstract] [PDF]


Home page
J Biomol ScreenHome page
C. J. Wilson, Y. Si, C. M. Thompsons, A. Smellie, M. A. Ashwell, J.-F. Liu, P. Ye, D. Yohannes, and S.-C. Ng
Identification of a Small Molecule That Induces Mitotic Arrest Using a Simplified High-Content Screening Assay and Data Analysis Method
J Biomol Screen, February 1, 2006; 11(1): 21 - 28.
[Abstract] [PDF]


Home page
J Biomol ScreenHome page
R. N. Ghosh, R. DeBiasio, C. C. Hudson, E. R. Ramer, C. L. Cowan, and R. H. Oakley
Quantitative Cell-Based High-Content Screening for Vasopressin Receptor Agonists Using Transfluor(R)Technology
J Biomol Screen, August 1, 2005; 10(5): 476 - 484.
[Abstract] [PDF]


Home page
J Biomol ScreenHome page
K. A. Giuliano, Y.-T. Chen, and D. L. Taylor
High-Content Screening with siRNA Optimizes a Cell Biological Approach to Drug Discovery: Defining the Role of P53 Activation in the Cellular Response to Anticancer Drugs
J Biomol Screen, October 1, 2004; 9(7): 557 - 568.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.